NPY5R, neuropeptide Y receptor Y5, 4889

N. diseases: 32; N. variants: 2
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs11724320
rs11724320
Entrez Id: 4886;4889
Gene Symbol: NPY1R;NPY5R
NPY1R;NPY5R
CUI: C0030319
Disease:
Panic Disorder
0.010 GeneticVariation BEFREE A synonymous (Gly-426-Gly) NPY Y5 coding variant (rs11946004) as well as haplotypes including rs11946004 and an intronic NPY Y5 variant (rs11724320) were significantly associated with panic disorder (P = 0.027), with the effect originating from the subgroup of female patients (P = 0.030), particularly with concurrent agoraphobia (P = 0.002-0.019). 17948870 2008
dbSNP: rs11724320
rs11724320
Entrez Id: 4886;4889
Gene Symbol: NPY1R;NPY5R
NPY1R;NPY5R
CUI: C0001818
Disease:
Agoraphobia
0.010 GeneticVariation BEFREE A synonymous (Gly-426-Gly) NPY Y5 coding variant (rs11946004) as well as haplotypes including rs11946004 and an intronic NPY Y5 variant (rs11724320) were significantly associated with panic disorder (P = 0.027), with the effect originating from the subgroup of female patients (P = 0.030), particularly with concurrent agoraphobia (P = 0.002-0.019). 17948870 2008
dbSNP: rs11946004
rs11946004
Entrez Id: 4889
Gene Symbol: NPY5R
NPY5R
CUI: C0030319
Disease:
Panic Disorder
0.010 GeneticVariation BEFREE A synonymous (Gly-426-Gly) NPY Y5 coding variant (rs11946004) as well as haplotypes including rs11946004 and an intronic NPY Y5 variant (rs11724320) were significantly associated with panic disorder (P = 0.027), with the effect originating from the subgroup of female patients (P = 0.030), particularly with concurrent agoraphobia (P = 0.002-0.019). 17948870 2008
dbSNP: rs11946004
rs11946004
Entrez Id: 4889
Gene Symbol: NPY5R
NPY5R
CUI: C0001818
Disease:
Agoraphobia
0.010 GeneticVariation BEFREE A synonymous (Gly-426-Gly) NPY Y5 coding variant (rs11946004) as well as haplotypes including rs11946004 and an intronic NPY Y5 variant (rs11724320) were significantly associated with panic disorder (P = 0.027), with the effect originating from the subgroup of female patients (P = 0.030), particularly with concurrent agoraphobia (P = 0.002-0.019). 17948870 2008